News
New subsidiary, Cynaptec Pharmaceuticals, established to hold global rights to Conjugated Psilocin™ $6 million investment in Cynaptec Pharmaceuticals secured to advance research and early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback